K Nonaka, T Kakikawa, A Sato, K Okuyama, G … - Diabetes research and …, 2008 - Elsevier Efficacy and tolerability of sitagliptin, a dipeptidyl peptidase-4 inhibitor, were assessed in Japanese
patients with type 2 diabetes. In a multicenter, double-blind, randomized, placebo-controlled
trial in Japan, 151 patients with inadequate glycemic control [HbA 1c ≥6.5% to <10%, ... Cited by 21 - Related articles - All 26 versions
- ►glycomark.com [PDF] KM Dungan - Expert Review of Molecular Diagnostics, 2008 - ingentaconnect.com 1,5-anhydroglucitol (1,5-AG) is a validated marker of short-term glycemic control. It is a metabolically
inert polyol that competes with glucose for reabsorption in the kidneys. Otherwise stable levels
of 1,5-AG are rapidly depleted as blood glucose levels exceed the renal threshold for ... Cited by 9 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org C Stettler, M Stahl, S Allemann, P Diem, K … - Diabetes Care, 2008 - Am Diabetes Assoc We thank Schindhelm et al. (1) for their highly valuable and important comment referring to our
study assessing the association of 1,5-anhydroglucitol (1,5-AG) with 2-h postprandial blood glucose
(2). We fully agree with these authors on the importance of impaired renal function as a ... Cited by 7 - Related articles - All 6 versions
- ►nih.gov [PDF] C Choe, S Edelman - Journal of the National Medical Association, 2007 - pubmedcentral.nih.gov Financial support: Dr. Edelman is a consultant and speaker for Novo, Lilly and Sanofi
Aventis, and has received grant support. Development of this manuscript was supported by Novo
Nordisk. Medical writing assistance was provided by Dr. Gary Patronek. Cited by 6 - Related articles - BL Direct - All 3 versions
H Yokoyama, S Kannno, I Ishimura, K Node - Metabolism, 2007 - Elsevier Postprandial hyperglycemia is associated with increased cardiovascular mortality; therefore,
lowering postprandial hyperglycemia seems crucial in type 2 diabetes mellitus. We assessed
the effect of 2 different postprandial glucose-lowering agents, the α-glucosidase inhibitor ... Cited by 6 - Related articles - All 14 versions
- ►glycomark.com [PDF] TM Nguyen, LM Rodriguez, KJ Mason, RA Heptulla - Pediatric Diabetes, 2007 - pt.wkhealth.com Postprandial hyperglycemia associated with diabetes is a risk factor for cardiovascular
disease. Currently, glycated hemoglobin A 1c (HgbA 1c ) and glycated protein fructosamine are
not sensitive markers for acute and short-term hyperglycemia. 1,5-Anhydroglucitol ... Cited by 4 - Related articles - BL Direct - All 5 versions
H Masuda, M Sakamoto, J Irie, A Kitaoka, … - Diabetes, obesity & …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 2 - Related articles - All 3 versions
AC Moses, P Raskin, N Khutoryansky - Diabetic Medicine, 2008 - pt.wkhealth.com Results: Baseline 1,5-AG was low and not significantly different (4.9 ± 3.5 and 4.3 ± 2.6 μg/ml
in the BIAsp 30 and IGlar groups, respectively). After 28 weeks, the levels of 1,5-AG were higher
in the BIAsp 30 than in the IGlar group (13.4 vs. 11.1 μg/ml, P = 0.008) and change from ... Cited by 2 - Related articles - BL Direct - All 4 versions
